DT-301

N/A

Report date: 2025/09/26 15:06:07
NME

Base Information

Drug NameDT-301
Drug Alias NameDT-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-3 modulatorsGamma-aminobutyric acid A receptor alpha-2 modulators
TargetsGamma-aminobutyric acid A receptor alpha-3Gamma-aminobutyric acid A receptor alpha-2
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDraig Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesDraig Therapeutics
Inactive CompaniesN/A
Active IndicationsMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A